n-methyl-3,4-methylenedioxyamphetamine has been researched along with MODS in 18 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| " We report a case of combined ecstasy/cocaine-induced fulminant hepatic failure presenting with severe rhabdomyolysis, myocardial infarction and multiorgan failure." | 3.72 | Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). ( Bauer, E; Kramer, L; Mallek, R; Schenk, P; Steininger, R; Vigl, M, 2003) |
| " The molecular mechanisms involved in the genesis of these toxic effects are not yet fully clarified, but the oxidative stress, excitotoxicity, and mitochondrial dysfunction appear to be causal events that converge to mediate MDMA-induced toxicity." | 2.46 | MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings. ( Bello, S; Fineschi, V; Neri, M; Riezzo, I; Turillazzi, E, 2010) |
| " Clinically important toxic effects have been reported, including fatalities." | 2.43 | Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. ( Hall, AP; Henry, JA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 6 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vakde, T | 1 |
| Diaz, M | 1 |
| Uday, K | 1 |
| Duncalf, R | 1 |
| Shelton, CP | 1 |
| Rosini, JM | 1 |
| Dahl, MK | 1 |
| Johansen, SS | 1 |
| Ramlau, J | 1 |
| Jensen, KA | 1 |
| Gee, P | 1 |
| Jerram, T | 1 |
| Bowie, D | 1 |
| Song, BJ | 1 |
| Moon, KH | 1 |
| Upreti, VV | 1 |
| Eddington, ND | 1 |
| Lee, IJ | 1 |
| Turillazzi, E | 1 |
| Riezzo, I | 1 |
| Neri, M | 1 |
| Bello, S | 1 |
| Fineschi, V | 1 |
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Kramer, L | 1 |
| Bauer, E | 1 |
| Schenk, P | 1 |
| Steininger, R | 1 |
| Vigl, M | 1 |
| Mallek, R | 1 |
| Ben-Abraham, R | 1 |
| Szold, O | 1 |
| Rudick, V | 1 |
| Weinbroum, AA | 1 |
| Lukasik-Głebocka, M | 1 |
| Wachowiak, R | 1 |
| Kostrzewa, A | 1 |
| Karlikowski, M | 1 |
| Mańkowski, W | 1 |
| Kołowski, J | 1 |
| Hall, AP | 2 |
| Henry, JA | 1 |
| Strobbe, L | 1 |
| de Jaer, CP | 1 |
| Louwerse, ES | 1 |
| Rozendaal, FW | 1 |
| Schilder, JN | 1 |
| Feldman, KW | 1 |
| Mazor, S | 1 |
| de Man, RA | 1 |
| Murthy, BV | 1 |
| Wilkes, RG | 1 |
| Roberts, NB | 1 |
| Trejo Gutiérrez, O | 1 |
| Ortega Romero, M | 1 |
| Perea Gainza, M | 1 |
| Nogué Xarau, S | 1 |
4 reviews available for n-methyl-3,4-methylenedioxyamphetamine and MODS
| Article | Year |
|---|---|
Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.
Topics: Animals; Hallucinogens; Humans; Mitochondria; Models, Biological; Multiple Organ Failure; N-Methyl-3 | 2010 |
MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.
Topics: Animals; Humans; Metabolic Clearance Rate; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphet | 2010 |
Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management.
Topics: Adolescent; Adult; Death, Sudden; Fever; Hallucinogens; Humans; Hyponatremia; Multiple Organ Failure | 2006 |
[Morbidity and mortality caused by use of ecstasy].
Topics: Chemical and Drug Induced Liver Injury; Humans; Multiple Organ Failure; N-Methyl-3,4-methylenedioxya | 1994 |
14 other studies available for n-methyl-3,4-methylenedioxyamphetamine and MODS
| Article | Year |
|---|---|
Rapidly reversible multiorgan failure after ingestion of "Molly" (pure 3,4-methylenedioxymethamphetamine): a case report.
Topics: Acute Kidney Injury; Adult; Heart Failure; Humans; Illicit Drugs; Male; Multiple Organ Failure; N-Me | 2014 |
Multisystem Organ Failure and Death Resulting From Ingestion of "Molly" (3,4-Methylenedioxymethamphetamine).
Topics: Adult; Emergency Nursing; Emergency Service, Hospital; Fatal Outcome; Humans; Illicit Drugs; Male; M | 2015 |
[Survival after severe ecstasy intoxication].
Topics: Adult; Brain Damage, Chronic; Drug Overdose; Forensic Toxicology; Hallucinogens; Humans; Male; Multi | 2008 |
Multiorgan failure from 1-benzylpiperazine ingestion--legal high or lethal high?
Topics: Drug Synergism; Female; Hallucinogens; Humans; Illicit Drugs; Male; Multiple Organ Failure; N-Methyl | 2010 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus).
Topics: Adult; Ammonia; Brain Edema; Cocaine; Encephalocele; Follow-Up Studies; Hepatic Encephalopathy; Huma | 2003 |
'Ecstasy' intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting.
Topics: Adolescent; Adult; Coma; Critical Care; Female; Hallucinogens; Humans; Illicit Drugs; Israel; Male; | 2003 |
[Clinical and toxicological evaluation of fatal poisoning with amphetamine derivative--MDMA, ecstasy (3,4-methylenedioxymethamphetamine)].
Topics: Acute Kidney Injury; Adolescent; Disseminated Intravascular Coagulation; Fatal Outcome; Humans; Live | 2004 |
[Fatal ecstasy intoxication in a 22-year-old man].
Topics: Adult; Fatal Outcome; Fever; Hallucinogens; Humans; Male; Multiple Organ Failure; N-Methyl-3,4-methy | 2007 |
[Fatal ecstasy intoxication in a 22-year-old man].
Topics: Adult; Hallucinogens; Humans; Male; Multiple Organ Failure; N-Methyl-3,4-methylenedioxyamphetamine | 2007 |
Ecstasy ingestion causing heatstroke-like, multiorgan injury in a toddler.
Topics: Administration, Oral; Child, Preschool; Follow-Up Studies; Humans; Male; Multiple Organ Failure; N-M | 2007 |
Creatine kinase isoform changes following Ecstasy overdose.
Topics: Creatine Kinase; Drug Overdose; Humans; Illicit Drugs; Isoenzymes; Male; Multiple Organ Failure; N-M | 1997 |
Ecstasy: creatinine kinase.
Topics: 3,4-Methylenedioxyamphetamine; Creatine Kinase; Dantrolene; Designer Drugs; Fever; Humans; Multiple | 1997 |
[Multiple organ failure associated with use of ecstasy].
Topics: Acute Disease; Adolescent; Hallucinogens; Humans; Male; Multiple Organ Failure; N-Methyl-3,4-methyle | 2001 |